Characteristics | t-PVP (n = 112) | ef-PVP (n = 105) | p |
---|---|---|---|
Age at surgery | 72.48 ± 6.68 | 72.15 ± 7.26 | 0.92U |
Gender | |||
Female | 92 (82.14%) | 80 (75.47%) | 0.32F |
Male | 20 (17.86%) | 25 (23.81%) | |
BMI (kg/m2) | 24.36 ± 4.31 | 24.17 ± 4.05 | 0.74T |
Hypertension | 48 (42.86%) | 46 (43.81%) | 0.89F |
Diabetes | 14 (12.50%) | 8 (7.62%) | 0.27F |
CHD | 8 (7.14%) | 7 (6.67%) | > 0.99F |
BMD (T-score) | − 3.18 ± 0.45 | − 3.24 ± 0.39 | 0.22U |
No. of fractures | |||
One | 104 (92.86%) | 92 (87.62%) | 0.11C |
Two | 5 (4.46%) | 12 (11.43%) | |
Three | 3 (2.68%) | 1 (0.95%) | |
Fracture site | 123 | 119 | |
T9 | 3 (2.43%) | 1 (0.84%) | 0.83C |
T10 | 7 (5.69%) | 7 (5.88%) | |
T11 | 8 (6.50%) | 14 (11.76%) | |
T12 | 30 (24.39%) | 30 (25.21%) | |
L1 | 37 (30.08%) | 34 (28.57%) | |
L2 | 24 (19.51%) | 17 (14.29) | |
L3 | 7 (5.69%) | 7 (5.88%) | |
L4 | 6 (4.88%) | 7 (5.88%) | |
L5 | 1 (0.81%) | 2 (1.68%) | |
Follow-up time (months) | 14.66 ± 1.88 | 14.93 ± 2.02 | 0.33U |